Posted by Louisiana Sportsman on April 15, 2014, at 12:18:37
In reply to Re: Dexedrine vs. Adderall pharmacology, posted by SheSaidWhat on April 4, 2014, at 11:42:36
I'm one of the few that may prefer Adderall due to the added l-amp over Dexedrine, but I'm currently on Dexedrine IR because I believe the absence of l-amp is better for my sporadic hypertension. Have you considered extended-release clonidine (Kapvay) or guanfacind (Intuniv) as a treatment option to augment?
I think first-line treatment should be Adderall IR or Dexedrine IR depending on the patient's cardiovascular health. It makes more sense to me than using an extended-release formulation stimulant that limits time of dosing and blood plasma levels.
ER should be administered only if the patient sees a need for it based upon their IR trial. While I'm solely prescribed Dexedrine IR, I could see how someone also might find the IR formulation useful as a "booster dose" when the ER effect dissipates.
Likewise, it is nobody's business that I take IR tablets. I think the societal aspect of not having to dose during the day possibly around peers plays a large part in the fact that ER meds seem to be used as first-line treatment more often, and that may not be the most therapeutic option.
poster:Louisiana Sportsman
thread:98610
URL: http://www.dr-bob.org/babble/20140328/msgs/1064263.html